Busch, Martin <br/><br/>
The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.  [electronic resource] 

 -  American journal of kidney diseases : the official journal of the National Kidney Foundation  Oct 2006 
 - 571-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1523-6838 
<br/><br/><label>Standard No.: </label>10.1053/j.ajkd.2006.07.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Angiopathies--blood<br/>Diabetic Nephropathies--blood<br/>Disease Progression<br/>Female<br/>Glycation End Products, Advanced--blood<br/>Humans<br/>Hypertension--blood<br/>Lysine--analogs & derivatives<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Oxidative Stress<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Risk Factors